Evidence map›Paper›PMID 31331030›Full record

ArticleInternational journal of molecular sciences2019

The Effect of Uncoated SPIONs on hiPSC-Differentiated Endothelial Cells.

Barbara Salingova, Pavel Simara, Pavel Matula, Lenka Zajickova, Petr Synek, Ondrej Jasek, Lenka Veverkova, Miroslava Sedlackova, Zuzana Nichtova, Irena Koutna

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Cytotoxicity of Dhanwantharaarishtam on hiPSC Cells - AnJournal of pharmacy & bioallied sciences · 2024
    Article
  3. Article
  4. Article
  5. Nanotechnology-Assisted Cell Tracking.Nanomaterials (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Barbara SalingovaCentre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Pavel SimaraCentre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.ORCID 0000-0001-7581-7048
Pavel MatulaCentre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Lenka ZajickovaRG Plasma Technologies, CEITEC-Masaryk University, Purkynova 656/123, 61200 Brno, Czech Republic.ORCID 0000-0002-6906-8906
Petr SynekDepartment of Physical Electronics, Faculty of Science, Masaryk University, Kotlarska 2, 60200 Brno, Czech Republic.ORCID 0000-0002-9590-2562
Ondrej JasekDepartment of Physical Electronics, Faculty of Science, Masaryk University, Kotlarska 2, 60200 Brno, Czech Republic.
Lenka Veverkova1st Surgical Department, Faculty of Medicine, Masaryk University and St. Ann's Hospital, Pekarska 53, 65691 Brno, Czech Republic.
Miroslava SedlackovaDepartment of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Zuzana NichtovaInstitute of Molecular Physiology and Genetics, Slovak Academy of Sciences, Dubravska Cesta 9, 84005 Bratislava, Slovak Republic.
Irena KoutnaCentre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. qkoutna@gmail.com.ORCID 0000-0002-1680-5052
Masaryk University · CZCentral European Institute of Technology · CZSlovak Academy of Sciences · SK

Funding

Agentura Pro Zdravotnický Výzkum České Republiky 16-31501A
6 · The paper itself

Abstract

backgroundEndothelial progenitor cells (EPCs) were indicated in vascular repair, angiogenesis of ischemic organs, and inhibition of formation of initial hyperplasia. Differentiation of endothelial cells (ECs) from human induced pluripotent stem cells (hiPSC)-derived endothelial cells (hiPSC-ECs) provides an unlimited supply for clinical application. Furthermore, magnetic cell labelling offers an effective way of targeting and visualization of hiPSC-ECs and is the next step towards in vivo studies.

methodsECs were differentiated from hiPSCs and labelled with uncoated superparamagnetic iron-oxide nanoparticles (uSPIONs). uSPION uptake was compared between hiPSC-ECs and mature ECs isolated from patients by software analysis of microscopy pictures after Prussian blue cell staining. The acute and long-term cytotoxic effects of uSPIONs were evaluated by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay) and Annexin assay.

resultsWe showed, for the first time, uptake of uncoated SPIONs (uSPIONs) by hiPSC-ECs. In comparison with mature ECs of identical genetic background hiPSC-ECs showed lower uSPION uptake. However, all the studied endothelial cells were effectively labelled and showed magnetic properties even with low labelling concentration of uSPIONs. uSPIONs prepared by microwave plasma synthesis did not show any cytotoxicity nor impair endothelial properties.

conclusionWe show that hiPSC-ECs labelling with low concentration of uSPIONs is feasible and does not show any toxic effects in vitro, which is an important step towards animal studies.

Indexed as

Cell DifferentiationFerric CompoundsMagnetite NanoparticlesBiomarkersCells, CulturedCell SurvivalEndothelial CellsHumansHuman Umbilical Vein Endothelial CellsImmunohistochemistryInduced Pluripotent Stem CellsBiomarkersFerric Compoundsferric oxideMagnetite Nanoparticlesdifferentiationhuman induced pluripotent stem cell-derived endothelial cellsmature endothelial cellsreprogrammingsuperparamagnetic iron-oxide nanoparticles

Identifiers

PMID31331030
PMCPMC6678752
OpenAlexW2963694468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.